IHH Healthcare Berhad Stocks

MYR 8.77Last Updated 27.04.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

MYR 19.67B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
MYR 8.77
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

IHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Europe, and internationally. It provides primary care services, such as treatment of common illnesses, outpatient treatment, routine check-ups, vaccinations, preventive care, and patient education services. The company also offers secondary services, including specialist consultation, local surgeries, emergency care, laboratory, diagnostics, and acute treatment services; tertiary care services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery. In addition, it provides ancillary services, including diagnostics, analytical laboratory testing, therapeutic radiology, physiotherapy, and integrated rehabilitation and advanced molecular diagnostics services. Further, the company offers medical education; train and develop nurses, doctors, allied healthcare professionals, and other medical and healthcare sector professionals; administrative, management, consultancy services; emergency, home, orthopedics, and ambulatory care services; healthcare information systems, web-based applications, and other technology solutions; and real estate investment trust services. Additionally, it operates dialysis and treasury centers, as well as educational institutions, colleges, schools, and other centers of learning, research, and education; develops, constructs, supervises, manages, and leases medical facility buildings and healthcare facilities; and provides catering, laundry, and cleaning services for hospitals, as well as imports and wholesales drug and medical materials. The company engages in the letting of properties; and software system integration and application management services. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 5225.KL is 8.5 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks